Zydus Capital Surpluse from 2010 to 2024

ZYDUSWELL   1,971  16.60  0.84%   
Zydus Wellness' Capital Surpluse is increasing over the years with slightly volatile fluctuation. Capital Surpluse is expected to dwindle to about 28.8 B. During the period from 2010 to 2024 Zydus Wellness Capital Surpluse annual values regression line had geometric mean of 0.00 and mean square error of 70424229.5 T. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
40.7 B
Current Value
28.8 B
Quarterly Volatility
17.2 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zydus Wellness financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zydus Wellness' main balance sheet or income statement drivers, such as Depreciation And Amortization of 249.9 M, Interest Expense of 195.5 M or Selling General Administrative of 319.1 M, as well as many indicators such as . Zydus financial statements analysis is a perfect complement when working with Zydus Wellness Valuation or Volatility modules.
  
This module can also supplement various Zydus Wellness Technical models . Check out the analysis of Zydus Wellness Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Zydus Stock

Zydus Wellness financial ratios help investors to determine whether Zydus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zydus with respect to the benefits of owning Zydus Wellness security.